Intracellular pathways underlying the effects of lithium
The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Abstract
This is a short overview focusing on the biochemical interactions underlying the protective effects of lithium at the neuronal level. These include lithium modulation of autophagy, growth factors, excitotoxicity, and a variety of mechanisms underlying cell death, neurogenesis, and neuronal differentiation. All these effects represent the result of a multifaceted pharmacology, which is becoming more and more complex. Nonetheless, when trying to dissect the various mechanisms of action of lithium, two primary targets emerge: glycogen synthase kinase 3beta and phosphatidylinositol phosphatase. The numerous lithium effects on biochemical systems are placed downstream of these two main mechanisms. At several steps, these mechanisms interconnect to each other, thus making it difficult to keep distinct the biochemical cascades promoted by lithium. In this way, it is not surprising that, despite being described as different phenomena at the behavioral level, molecular mechanisms underlying the effects of lithium on mood, motor activity, and sensitization overlap with those responsible for neuroprotection and neurorestoration. It is likely that the ancestral role of this ion as a modulator of cell survival, cell growth, movement, and mood is the consequence of a few molecular mechanisms operating in different neuronal networks, where a variety of cascade events take place. This review is an attempt to elucidate the primary effects of lithium to interconnect the simpler targets to the most complex pharmacological effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A role for Wnt signalling in self-renewal of haematopoietic stem cells
Reya, T., Duncan, A. W., Ailles, L., Domen, J., Scherer, D. C., Willert, K., Hintz, L., Nusse, R., & Weissman, I. L. (2003) · Nature · doi:10.1038/nature01593 · Cited by 2,159 · cited 2×
“Wnt signaling is involved in hematopoiesis, as Wnt ligands enhance proliferation of hematopoietic stem cells (HSCs) ex vivo and Wnt antagonists inhibit HSC proliferation and reconstitution (Reya et al., 2003; Jeannet et al., 2008).”
BackgroundDeficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein
De Strooper, B., Saftig, P., Craessaerts, K., Vanderstichele, H., Guhde, G., Annaert, W., Von Figura, K., & Van Leuven, F. (1998) · Nature · doi:10.1038/34910 · Cited by 1,818 · cited 2×
“Abeta peptides derive from the amyloid precursor protein (APP) by sequential proteolysis, catalyzed by the aspartyl protease BACE2, followed by presenilin-dependent gsecretase cleavage (De Strooper et al., 1998).”
BackgroundVascular endothelial growth factor (VEGF) stimulates neurogenesis in vitro and in vivo
Jin, K., Zhu, Y., Sun, Y., Mao, X. O., Xie, L., & Greenberg, D. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182296499 · Cited by 1,507
α-Synuclein Is Degraded by Both Autophagy and the Proteasome
Webb, J. L., Ravikumar, B., Atkins, J., Skepper, J. N., & Rubinsztein, D. C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300227200 · Cited by 1,429
Inoki, K., Ouyang, H., Zhu, T., Lindvall, C., Wang, Y., Zhang, X., Yang, Q., Bennett, C., Harada, Y., Stankunas, K., et al. (2006) · Cell · doi:10.1016/j.cell.2006.06.055 · Cited by 1,377
Molecular cloning and expression of glycogen synthase kinase‐3/factor A.
Woodgett, J. R. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb07419.x · Cited by 1,362
Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells
Stambolic, V., Ruel, L., & Woodgett, J. R. (1996) · Current Biology · doi:10.1016/s0960-9822(02)70790-2 · Cited by 1,321
Lithium induces autophagy by inhibiting inositol monophosphatase
Sarkar, S., Floto, R. A., Berger, Z., Imarisio, S., Cordenier, A., Pasco, M., Cook, L. J., & Rubinsztein, D. C. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200504035 · Cited by 985 · cited 22×
“cellular levels of inositol-1,4,5-triphosphate (IP3) (Berridge and Irvine, 1989; Sarkar et al., 2005; Sarkar and Rubinsztein, 2006), accumulation of inositol 1-monophosphate [Ins(1)P]”
BackgroundInfluentialSutherland, C., Leighton, I. A., & Cohen, P. (1993) · Biochemical Journal · doi:10.1042/bj2960015 · Cited by 903 · cited 2×
“…various intracellular PKs, including cyclic adenosine monophosphate-dependent protein kinase A (Fang et al., 2000), ribosomal protein S6 kinase (p90RSK) (Sutherland et al., 1993; Eldar-Finkelman et al., 1995), protein kinase B (Cross et al., 1995), and PKC (Goode et al., 1992; Fang et al., 2002).”
BackgroundMolecular Interplay between Mammalian Target of Rapamycin (mTOR), Amyloid-β, and Tau
Caccamo, A., Majumder, S., Richardson, A., Strong, R., & Oddo, S. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.100420 · Cited by 881
Acetylation Is Indispensable for p53 Activation
Tang, Y., Zhao, W., Chen, Y., Zhao, Y., & Gu, W. (2008) · Cell · doi:10.1016/j.cell.2008.03.025 · Cited by 838
β-catenin: a key mediator of Wnt signaling
Willert, K., & Nusse, R. (1998) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(98)80068-3 · Cited by 753
Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease
Garcia-Alloza, M., Robbins, E. M., Zhang-Nunes, S. X., Purcell, S. M., Betensky, R. A., Raju, S., Prada, C., Greenberg, S. M., Bacskai, B. J., & Frosch, M. P. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.08.017 · Cited by 744
Noble, W., Planel, E., Zehr, C., Olm, V., Meyerson, J., Suleman, F., Gaynor, K., Wang, L., LaFrancois, J., Feinstein, B., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0500466102 · Cited by 709 · cited 2×
“Tau phosphorylation is reduced at specific sites targeted by GSK-3b in transgenic mice overexpressing FTDP-17 tau (Pérez et al., 2003a; Noble et al., 2005), and in a mouse model overexpressing the shorter human tau isoform (Nakashima et al., 2005) and in 3xTg-AD mice (Caccamo et al., 2007).”
BackgroundAlzheimer disease and cerebrovascular pathology: an update
Jellinger, K. A. (2002) · Journal of Neural Transmission · doi:10.1007/s007020200068 · Cited by 680 · cited 2×
“…the neuropathological hallmarks are the senile plaques, deposition of amyloid-b peptides in the neuropil (Jellinger and Bancher, 1998) and around blood vessels (Jellinger, 2002), and the intraneuronal neurofibrillary tangles (NFTs) formed by hyperphosphorylated tau, a microtubule-binding protein.”
BackgroundLithium delays progression of amyotrophic lateral sclerosis
Fornai, F., Longone, P., Cafaro, L., Kastsiuchenka, O., Ferrucci, M., Manca, M. L., Lazzeri, G., Spalloni, A., Bellio, N., Lenzi, P., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708022105 · Cited by 550
Self-citationAcetylation of p53 inhibits its ubiquitination by Mdm2
Li, M., Luo, J., Brooks, C. L., & Gu, W. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c200578200 · Cited by 503
Ishiguro, K., Shiratsuchi, A., Sato, S., Omori, A., Arioka, M., Kobayashi, S., Uchida, T., & Imahori, K. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)81066-9 · Cited by 402
Yasuda, S., Liang, M.-H., Marinova, Z., Yahyavi, A., & Chuang, D.-M. (2009) · Molecular Psychiatry · doi:10.1038/sj.mp.4002099 · Cited by 358 · cited 4×
“element(s) in the promoter region between – 170 and – 710 bp (Yasuda et al., 2009).”
BackgroundInfluentialTardito, D., Perez, J., Tiraboschi, E., Musazzi, L., Racagni, G., & Popoli, M. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.1.7 · Cited by 303 · cited 1×
“It is likely that molecular mechanisms underlying the effects of Li + on mood, motor activity, and sensitization overlap with those responsible for neuroprotection and neurorestoration (Tardito et al., 2006; Xu et al., 2009).”
BackgroundZanarini, M. C., Frankenburg, F. R., Hennen, J., & Silk, K. R. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0105 · Cited by 285
McQueen, M. B., Devlin, B., Faraone, S. V., Nimgaonkar, V. L., Sklar, P., Smoller, J. W., Abou Jamra, R., Albus, M., Bacanu, S.-A., Baron, M., et al. (2005) · The American Journal of Human Genetics · doi:10.1086/491603 · Cited by 245 · cited 1×
“Chromosome 8q24 is a susceptibility region for bipolar disorder (Cichon et al., 2001; McInnis et al., 2003; Avramopoulos et al., 2004; McQueen et al., 2005).”
BackgroundLazarus, J. H. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2009.06.002 · Cited by 230 · cited 2×
“By inhibiting the activity of the thyroid-stimulating hormone action on cyclic adenosine monophosphate, Li + inhibits T4 hormone release and decreases T4 clearance from plasma (Lazarus, 2009).”
BackgroundEngel, T., Goñi‐Oliver, P., Lucas, J. J., Avila, J., & Hernández, F. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04139.x · Cited by 223 · cited 4×
“…Sarkar et al., 2008; Parkinson’s disease (PD), Youdim and Arraf, 2004; Prion diseases, Heiseke et al., 2009; ALS, Fornai et al., 2008a; cerebellar ataxia, Watase et al., 2007; inclusionbody myositis, Askanas and Engel, 2008; dementia, Zhong and Lee, 2007; Engel et al., 2006; Ghosal et al., 2009].”
BackgroundInfluentialRosenstein, J. M., Mani, N., Khaibullina, A., & Krum, J. M. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-35-11036.2003 · Cited by 220 · cited 2×
“VEGF promotes neurogenesis (Jin et al., 2002; Zhu et al., 2003), stimulates neurite outgrowth (Sondell et al., 2000; Rosenstein et al., 2003), and protects against stress, (Jin et al., 2000), glutamate excitotoxicity (Matsuzaki et al., 2001; Tolosa et al., 2008), and hypoxia (Ogunshola et al.,…”
BackgroundGlycogen synthase kinase-3β phosphorylates tau protein at multiple sites in intact cells
Sperbera, B. R., Leight, S., Goedert, M., & Lee, V. M.-Y. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11902-9 · Cited by 204 · cited 2×
“GSK-3b is involved in tau hyperphosphorylation (Sperber et al., 1995) and”
BackgroundBenedetti, F., Serretti, A., Pontiggia, A., Bernasconi, A., Lorenzi, C., Colombo, C., & Smeraldi, E. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2004.11.022 · Cited by 184 · cited 1×
“These studies identified a polymorphism for the therapeutic response to Li + in bipolar patients (Benedetti et al., 2005).”
BackgroundAskanas (2006) · doi:10.1212/01.wnl.0000192128.13875.1e · Cited by 168 · cited 1×
“These aggregates also contain other proteins, such as a-synuclein, presenilin1, apolipoprotein E, and ubiquitin (Askanas et al., 1993, 1996, 1998; Askanas and Engel, 2006, 2008).”
BackgroundPandey, G. N., Dwivedi, Y., Rizavi, H. S., Ren, X., Zhang, H., & Pavuluri, M. N. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.03.003 · Cited by 118 · cited 1×
“In fact reduced BDNF levels are described in depression (Bocchio-Chiavetto et al., 2010; Pandey et al., 2010).”
BackgroundLee, K. Y., Ahn, Y. M., Joo, E.-J., Jeong, S.-H., Chang, J. S., Kim, S.-C., & Kim, Y. S. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2005.10.059 · Cited by 54 · cited 2×
“However, the association between mood disorders and polymorphisms for GSK-3b remains under debate, as this was not obsrved in studies in a Korean population (Lee et al., 2006; Yoon and Kim, 2010).”
BackgroundKnockout mice in understanding the mechanism of action of lithium
Agam, G., Bersudsky, Y., Berry, G. T., Moechars, D., Lavi-Avnon, Y., & Belmaker, R. H. (2009) · Biochemical Society Transactions · doi:10.1042/bst0371121 · Cited by 50
Cited by
The Concise Guide to PHARMACOLOGY 2013/14: Enzymes
Alexander, S. P. H., Benson, H. E., Faccenda, E., Pawson, A. J., Sharman, J. L., Spedding, M., Peters, J. A., Harmar, A. J., & Collaborators, C. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12451 · Cited by 425
Baldessarini, R. J. (2013) · doi:10.1007/978-1-4614-3710-9 · Cited by 365
Forlenza, O. V., De-Paula, V. J. R., & Diniz, B. S. O. (2014) · ACS Chemical Neuroscience · doi:10.1021/cn5000309 · Cited by 332
Long-term lithium treatment in bipolar disorder is associated with longer leukocyte telomeres
Martinsson, L., Wei, Y., Xu, D., Melas, P. A., Mathé, A. A., Schalling, M., Lavebratt, C., & Backlund, L. (2013) · Translational Psychiatry · doi:10.1038/tp.2013.37 · Cited by 179
“Thus, in the form of downstream events, lithium influences a variety of biochemical systems that are involved in neuronal survival and differentiation.(40,42,43) Because of the numerous downstream molecular targets of GSK-3b, the abundance of hTERT regulators and the plethora of enzymes dependent on Mg2þ with which Li…”
BackgroundLithium: the pharmacodynamic actions of the amazing ion
Brown, K. M., & Tracy, D. K. (2013) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125312471963 · Cited by 140
“…inositol monophosphatase (IMPase) within the phosphatidylinositol (PI) signalling pathway [Berridge et al. 1989] and the protein kinase glycogen synthase kinase 3β (GSK-3β) [Ryves and Harwood, 2001], although therapeutic effects may be due to further downstream effects [Pasquali et al. 2010].”
BackgroundInfluential
Metadata
- Authors
- Pasquali, L., Busceti, C. L., Fulceri, F., Paparelli, A., & Fornai, F.
- Venue
- Behavioural Pharmacology
- Published
- 2010-09
- Volume
- 21
- Issue
- 5-6
- Pages
- 473-492
- ISSN
- 0955-8810 (ISSN-L)
- OpenAlex
- W1985380799
- Cited by
- 112
- References
- 31
- FWCI
- 5.78
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.